Health
    Socio-economy & New Tech

    Medical Treatment & Drug Development

    Biotech- and Nanotechnology

    Drug Delivery

Post-Doctoral Fellowships

France

Theoretical study of plasma expansion into a vacuum and of the acceleration of high energy ion

Radiation therapy using X-rays to kill cancer cells has disadvantages, like the inability to penetrate very far into the body. Dr. Cédric Thaury is working on alternatives: beams of high-energy particles—electrons or protons—that are fired at a tumor to destroy the cancerous cells. He is developing new tools, based on laser-plasma interaction, to produce and control these beams for precise, effective treatment of tumors with fewer side effects. Developing less costly systems would also allow for greater use of these therapies.

Taking aim at tumors

Scientific title: Theoretical study of plasma expansion into a vacuum and of the acceleration of high energy ion beams during the interaction of a high intensity laser with a plasma

To add or modify information on this page, please contact us at the following address: community.research@axa.com

Cédric
THAURY

Institution

Ecole Polytechnique

Country

France

Nationality

French

ORCID Open Researcher and Contributor ID, a unique and persistent identifier to researchers

Related publications

Health

Health Technologies

Medical Treatment & Drug Development

Biotech- and Nanotechnology

Drug Delivery

France

Abolishing frontiers between fundamental science and medicine : building on the potential of biomedical ultrasound

Read more

Mickaël
TANTER

Institut National de la Santé et de la Recherche Médicale

Health

Chronic & Non Communicable Diseases

Medical Treatment & Drug Development

Cancer

Clinical Data & Trials

Biotech- and Nanotechnology

Spain

Liquid biopsies : a promising alternative for cancer detection

Read more

João
MIGUEL ALVES

Universidade de Vigo

Health

Medical Treatment & Drug Development

Pandemics & Infectious Diseases

Antimicrobials, Antibiotics & Drug Resistances

Bacteria & Other Microorganisms

France

Pharmacodiversity Oriented Synthesis: A New Tool For The Rapid Discovery Of Treatment For Multidrug-Resistant Bacteria

Read more

Andrew Christopher
SILVANUS

Université de Versailles Saint-Quentin-en-Yvelines